Swiss National Bank reduced its position in LHC Group, Inc. (NASDAQ:LHCG – Get Rating) by 0.4% in the 2nd quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 70,866 shares of the health services provider’s stock after selling 300 shares during the quarter. Swiss National Bank owned about 0.23% of LHC Group worth $11,037,000 at the end of the most recent reporting period.
Several other hedge funds have also recently added to or reduced their stakes in the company. Pictet Asset Management SA raised its stake in LHC Group by 17.0% in the 2nd quarter. Pictet Asset Management SA now owns 243,174 shares of the health services provider’s stock valued at $37,872,000 after purchasing an additional 35,355 shares during the last quarter. Alpine Associates Management Inc. raised its stake in LHC Group by 362.5% in the 2nd quarter. Alpine Associates Management Inc. now owns 827,800 shares of the health services provider’s stock valued at $128,922,000 after purchasing an additional 648,800 shares during the last quarter. Keebeck Alpha LP purchased a new stake in LHC Group in the 2nd quarter valued at $3,256,000. Walleye Capital LLC grew its holdings in LHC Group by 629.1% in the 2nd quarter. Walleye Capital LLC now owns 39,355 shares of the health services provider’s stock valued at $6,129,000 after buying an additional 33,957 shares in the last quarter. Finally, Mint Tower Capital Management B.V. grew its holdings in LHC Group by 30.1% in the 2nd quarter. Mint Tower Capital Management B.V. now owns 9,109 shares of the health services provider’s stock valued at $1,419,000 after buying an additional 2,109 shares in the last quarter. 87.82% of the stock is owned by institutional investors and hedge funds.
Wall Street Analyst Weigh In
Separately, StockNews.com assumed coverage on LHC Group in a report on Wednesday, October 12th. They issued a “hold” rating for the company. Nine research analysts have rated the stock with a hold rating, Based on data from MarketBeat.com, LHC Group currently has a consensus rating of “Hold” and an average price target of $172.50.
LHC Group Stock Performance
LHC Group Company Profile
LHC Group, Inc, a health care provider, specializes in the post-acute continuum of care primarily for Medicare beneficiaries in the United States. It operates through five segments: Home Health Services, Hospice Services, Home and Community-Based Services, Facility-Based Services, and Healthcare Innovations (HCI).
- Get a free copy of the StockNews.com research report on LHC Group (LHCG)
- MarketBeat: Week in Review 11/14 – 11/18
- Target’s Double Bottom Might Have Just Been Confirmed
- How High Can the Fed Go? How to Trade it
- Does ASML’s November Rally Have Staying Power?
- Verra Mobility Stock Has Returned Back to the Station
Receive News & Ratings for LHC Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LHC Group and related companies with MarketBeat.com's FREE daily email newsletter.